Jul 1, 2026 · 25 min · 10 segments
Kristin Conor, CEO of Cure Childhood Cancer, joins Timothy Chou to share the personal story of her son Brandon’s neuroblastoma diagnosis and how it led her from law into pediatric cancer advocacy. She…
Kristin ConnorGuest
Timothy ChouHost
I think science is that such an exciting point in time with, you know, the the completion of the Human Genome Project back in the early 2000s and then the technology that has advanced so much and we now were able to map a child's tumor and see what's happening at the genetic level driving cancer and then really work to develop these targeted therapies that can like maybe turn that off, right? The cancer growing gene or mutation.
And now that's becoming more and more standard of care, you know, and I think that we need that research to continue and then, you know, you have the, you know, AI, you know, now that's really, you know, exploding too and immunotherapies and just, it's just never been, I think, a more exciting time for scientific progress.
And so, you know, what happens now? And so I think, you know, it's hard to predict you know, where we're going and what the next, you know, five or 10 years looks like.
If the funding situation wasn't what it was, if we were back a couple of years, then I would just tell you, I'm just so optimistic that we're going to make, that progress is going to really accelerate, right? And we're going to see drastic changes within the next decade and how we're treating childhood cancer and other diseases.
I think science is that such an exciting point in time with, you know, the the completion of the Human Genome Project back in the early 2000s and then the technology that has advanced so much and we now were able to map a child's tumor and see what's happening at the genetic level driving cancer and then really work to develop these targeted therapies that can like maybe turn that off, right? The cancer growing gene or mutation.
And now that's becoming more and more standard of care, you know, and I think that we need that research to continue and then, you know, you have the, you know, AI, you know, now that's really, you know, exploding too and immunotherapies and just, it's just never been, I think, a more exciting time for scientific progress.
And so, you know, what happens now? And so I think, you know, it's hard to predict you know, where we're going and what the next, you know, five or 10 years looks like.
If the funding situation wasn't what it was, if we were back a couple of years, then I would just tell you, I'm just so optimistic that we're going to make, that progress is going to really accelerate, right? And we're going to see drastic changes within the next decade and how we're treating childhood cancer and other diseases.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
